0001183740-17-000149.txt : 20170818 0001183740-17-000149.hdr.sgml : 20170818 20170818140411 ACCESSION NUMBER: 0001183740-17-000149 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 EFFECTIVENESS DATE: 20170818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293125 FILM NUMBER: 171040790 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D 1 primary_doc.xml X0708 D LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 416-847-6898 CANADA (FEDERAL LEVEL) AMORFIX LIFE SCIENCES LTD Corporation true Elliot Goldstein Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Neil Cashman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director Patrick D. Kirwin Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Johannes Roth Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Eugene Williams Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director William Wyman Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Richard Gregory Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Anthony Giovinazzo Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Director Janet Clennett Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Johanne Kaplan Suite 200, 1920 Yonge Street Toronto A6 ONTARIO, CANADA M4S 3E2 Executive Officer Biotechnology Decline to Disclose 06b false 2017-08-09 true true true true true Units at C$0.25 per Unit (comprised of one common share and one-half of one common share purchase warrant, exercisable into a share at C$0.30 for five years.) false 0 Noble Capital Markets, Inc. 15768 None None 225 NE Mizner Blvd, Suite 150 Boca Raton FL FLORIDA 33432 CA CALIFORNIA FL FLORIDA MA MASSACHUSETTS NY NEW YORK false 3840000 644061 3195939 Offering Amount equals price of units(12000000units x C$0.25(US$0.20)) plus aggregate exercise price of warrants forming part of the units(6000000warrants x C$0.30($0.24)).Amount Sold equals price of units sold on 8/9/2017(3,220,306units x C$0.25($0.20)). false 13 39866 true 0 Placement fees in the amount of US$39,866.15 representing 7% of the gross proceeds from the sale of Units. Noble Capital Markets Inc. also received 199,330 warrants, exercisable at C$0.285 per share for five years. 0 false ProMIS Neurosciences Inc. /s/ Elliot Goldstein Elliot Goldstein President and CEO 2017-08-16